论文信息 - Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis - 字舞流文

Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis

Y. Al-Tonbary | F. Tricta | M. Badr | Y. Kilinç | Y. Wali | Z. Karakaş | M. Qari | A. Stilman | M. Salama | Usama R. Elsafy | M. Elalfy | Z. A. al Hawsawi | S. Shebl | D. Yazman | Noemi Toiber Temin | Ghazi Al Damanhouri | M. Akif Yesilipek | Yousryeia Abdel Rahman | M. A. Yesilipek